-
Je něco špatně v tomto záznamu ?
Tomm34 is commonly expressed in epithelial ovarian cancer and associates with tumour type and high FIGO stage
P. Muller, PJ. Coates, R. Nenutil, F. Trcka, R. Hrstka, J. Chovanec, V. Brychtova, B. Vojtesek,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
Grantová podpora
ADOPT BBMRI-ERIC No. 676550
Horizon 2020
GACR 16-07321S
Grantová Agentura České Republiky
NPS I - LO1413
Ministerstvo Školství, Mládeže a Tělovýchovy
LM2015089
Ministerstvo Školství, Mládeže a Tělovýchovy
DRO - MMCI 00209805
Ministerstvo Zdravotnictví Ceské Republiky
NLK
BioMedCentral
od 2008-12-01
BioMedCentral Open Access
od 2008
Directory of Open Access Journals
od 2008
Free Medical Journals
od 2008
PubMed Central
od 2008
Europe PubMed Central
od 2008 do 2020
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2008-01-01
Open Access Digital Library
od 2008-01-01
Health & Medicine (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2008
Springer Nature OA/Free Journals
od 2008-12-01
- MeSH
- dospělí MeSH
- epiteliální ovariální karcinom metabolismus patologie MeSH
- imunohistochemie MeSH
- lidé středního věku MeSH
- lidé MeSH
- mutace MeSH
- nádorové biomarkery genetika metabolismus MeSH
- nádorový supresorový protein p53 genetika MeSH
- nádory vaječníků metabolismus patologie MeSH
- prognóza MeSH
- progrese nemoci MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- staging nádorů MeSH
- transportní proteiny mitochondriální membrány metabolismus MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Increased activity of the chaperones Hsp70 and Hsp90 is a common feature of solid tumours. Translocase of the outer mitochondrial membrane 34 (Tomm34) is a cochaperone of both Hsp70 and Hsp90 that was found to be overexpressed in colorectal, hepatocellular, lung and breast carcinomas. The expression profile of Tomm34 in ovarian cancer has not been investigated. Therefore, the aim of the current study was to investigate the expression pattern of Tomm34 in ovarian carcinomas and analyse its correlation with clinico-pathological parameters. RESULTS: Epithelial ovarian cancers (140) were histologically classified based on their morphology and graded into two types comprising 5 histologic subgroups. Type I carcinomas comprise low grade serous (LGSC), clear cell (CCOC) and endometrioid (ENOC), type II comprises high grade serous carcinomas (HGSC) and solid, pseudoendometrioid, transitional carcinomas (SET). Tomm34 was more highly expressed in type II than type I carcinomas (p < 0.0001). Comparing tumours based on the mutation in the TP53 gene revealed similar results, where mutant tumours exhibited significantly higher levels of Tomm34 (p < 0.0001). The decreased levels of Tomm34 in type I carcinomas were particularly evident in clear cell and mucinous carcinomas. The expression of Tomm34 was also positively correlated with FIGO stage (r = 0.23; p = 0.007). Tomm34 levels also indicated poor prognosis for patients with mutant p53. CONCLUSIONS: Our data indicate that Tomm34 is commonly expressed at high levels in epithelial ovarian cancers, except for the clear cell and mucinous subtypes. The expression of Tomm34 corresponds with the dualistic model of ovarian cancer pathogenesis where high grade, type II tumours exhibit higher expression of Tomm34 in contrast to type I tumours. These data are also comparable to the previous findings that Tomm34 is a marker of progression and poor prognosis in human cancer.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19034686
- 003
- CZ-PrNML
- 005
- 20191031103939.0
- 007
- ta
- 008
- 191007s2019 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s13048-019-0498-0 $2 doi
- 035 __
- $a (PubMed)30917858
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Muller, Petr $u Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53, Brno, Czech Republic.
- 245 10
- $a Tomm34 is commonly expressed in epithelial ovarian cancer and associates with tumour type and high FIGO stage / $c P. Muller, PJ. Coates, R. Nenutil, F. Trcka, R. Hrstka, J. Chovanec, V. Brychtova, B. Vojtesek,
- 520 9_
- $a BACKGROUND: Increased activity of the chaperones Hsp70 and Hsp90 is a common feature of solid tumours. Translocase of the outer mitochondrial membrane 34 (Tomm34) is a cochaperone of both Hsp70 and Hsp90 that was found to be overexpressed in colorectal, hepatocellular, lung and breast carcinomas. The expression profile of Tomm34 in ovarian cancer has not been investigated. Therefore, the aim of the current study was to investigate the expression pattern of Tomm34 in ovarian carcinomas and analyse its correlation with clinico-pathological parameters. RESULTS: Epithelial ovarian cancers (140) were histologically classified based on their morphology and graded into two types comprising 5 histologic subgroups. Type I carcinomas comprise low grade serous (LGSC), clear cell (CCOC) and endometrioid (ENOC), type II comprises high grade serous carcinomas (HGSC) and solid, pseudoendometrioid, transitional carcinomas (SET). Tomm34 was more highly expressed in type II than type I carcinomas (p < 0.0001). Comparing tumours based on the mutation in the TP53 gene revealed similar results, where mutant tumours exhibited significantly higher levels of Tomm34 (p < 0.0001). The decreased levels of Tomm34 in type I carcinomas were particularly evident in clear cell and mucinous carcinomas. The expression of Tomm34 was also positively correlated with FIGO stage (r = 0.23; p = 0.007). Tomm34 levels also indicated poor prognosis for patients with mutant p53. CONCLUSIONS: Our data indicate that Tomm34 is commonly expressed at high levels in epithelial ovarian cancers, except for the clear cell and mucinous subtypes. The expression of Tomm34 corresponds with the dualistic model of ovarian cancer pathogenesis where high grade, type II tumours exhibit higher expression of Tomm34 in contrast to type I tumours. These data are also comparable to the previous findings that Tomm34 is a marker of progression and poor prognosis in human cancer.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a nádorové biomarkery $x genetika $x metabolismus $7 D014408
- 650 _2
- $a epiteliální ovariální karcinom $x metabolismus $x patologie $7 D000077216
- 650 _2
- $a progrese nemoci $7 D018450
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunohistochemie $7 D007150
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a transportní proteiny mitochondriální membrány $x metabolismus $7 D033681
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a staging nádorů $7 D009367
- 650 _2
- $a nádory vaječníků $x metabolismus $x patologie $7 D010051
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a nádorový supresorový protein p53 $x genetika $7 D016159
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Coates, Philip J $u Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53, Brno, Czech Republic.
- 700 1_
- $a Nenutil, Rudolf $u Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53, Brno, Czech Republic.
- 700 1_
- $a Trcka, Filip $u Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53, Brno, Czech Republic.
- 700 1_
- $a Hrstka, Roman $u Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53, Brno, Czech Republic.
- 700 1_
- $a Chovanec, Josef $u Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53, Brno, Czech Republic.
- 700 1_
- $a Brychtova, Veronika $u Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53, Brno, Czech Republic.
- 700 1_
- $a Vojtesek, Borivoj $u Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53, Brno, Czech Republic. vojtesek@mou.cz.
- 773 0_
- $w MED00200602 $t Journal of ovarian research $x 1757-2215 $g Roč. 12, č. 1 (2019), s. 30
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30917858 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20191007 $b ABA008
- 991 __
- $a 20191031104419 $b ABA008
- 999 __
- $a ok $b bmc $g 1451346 $s 1073236
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 12 $c 1 $d 30 $e 20190327 $i 1757-2215 $m Journal of ovarian research $n J Ovarian Res $x MED00200602
- GRA __
- $a ADOPT BBMRI-ERIC No. 676550 $p Horizon 2020
- GRA __
- $a GACR 16-07321S $p Grantová Agentura České Republiky
- GRA __
- $a NPS I - LO1413 $p Ministerstvo Školství, Mládeže a Tělovýchovy
- GRA __
- $a LM2015089 $p Ministerstvo Školství, Mládeže a Tělovýchovy
- GRA __
- $a DRO - MMCI 00209805 $p Ministerstvo Zdravotnictví Ceské Republiky
- LZP __
- $a Pubmed-20191007